Millions Logo
home>US Stocks>Latigo Biotherapeutics
LTGO
Latigo BiotherapeuticsHealthcare
$12.88$-5.12 (-28.44%)in 1 year
As on 13 Nov 2026 at 02:29NASDAQ

Latigo Biotherapeutics Share Price Today

Latigo Biotherapeutics opened lower at $13.35, compared with its previous close of $13.52. In the last trading session, the stock traded between $12.20 and $13.59. It showed a downward intraday trend.

Return calculator

Time Period

An investment of $100 made 1 year ago in Latigo Biotherapeutics is now worth

$ 71.56

Resulting in a loss of

$ 28.44 (28.44%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Buy

Rating from 3 Analysts

Buy
100%
Hold
0%
Sell
0%

Markets Today

Today's Change

$-0.64 (-4.73%)

Day High

$13.59

Day Low

$12.20

Day Open

$13.35

Prev Close

$13.52

Volume

1,18,832

1W Return

-8.19%

1M Return

-19.47%

3M Return

-30.61%

6M Return

-28.44%

1Y Return

-28.44%

Fundamentals

Market Cap ($ Mn)

-

PE Ratio

-

PB Ratio

-

PEG Ratio

-

ROE

-

ROCE

-

EPS (TTM)

-

Investment Returns

1 Week

-8.19%

1 Month

-19.47%

3 Months

-30.61%

6 Months

-28.44%

9 Months

-28.44%

Financials

Quarterly
All values in $ Mn
0.0

Mar 25
0.0

Jun 25
0.0

Mar 26
0.0

Jun 26

Updates

5Nov

Latigo Biotherapeutics reports $20.9 million net loss in Q3 2026

Net loss narrowed to $20.9 million in Q3 2026 from $24.8 million in Q3 2025. Cash position stands at $401.2 million, expected to fund operations into 2029. R&D expenses declined to $17.5 million while G&A rose to $5.4 million. Phase 3 bunionectomy trial adds Percocet arm; topline results expected H2 2027.

7 days ago

Similar Stocks

StockLTPChange %Market CapPE
$547.03-0.16%$1,38,692.89M31.55
$61.05+0.38%$1,31,510.31M14.39
$248.69-0.85%$1,00,625.20M-
$959.41+4.73%$97,505.80M19.64
$977.58+0.62%$61,476.10M38.99
$419.98-0.95%$46,108.31M65.60
$180.70-6.40%$39,083.96M-
$53.87-0.37%$33,618.11M26.24
$70.01+0.81%$31,173.07M32.37
$41.85+1.60%$30,322.88M-
$120.75+1.05%$26,490.14M-
$122.27+1.64%$24,922.54M15.85